| Literature DB >> 24561219 |
Y Wang1, H Wang1, Y Tao1, S Zhang1, J Wang2, X Feng3.
Abstract
Spinal cord injury (SCI) is a common and serious trauma which lacks efficient treatment. Inhibition of cell death in the trauma area is important for spinal cord protection during this process. In this study, necroptosis inhibitor necrostatin-1 (Nec-1) was used to treat SCI rats, to investigate the role of Nec-1 in the recovery of SCI. Nec-1 was found to reduce lesions, cytokines and reactive oxygen species (ROS), improve pathological conditions and blood supply in the spinal cord trauma area. Further study indicated that Nec-1 could inhibit necroptosis by inhibiting RIP1/3-MLKL recruitment and inhibit apoptosis by inhibiting Caspase 3 and Bax while activating Bcl-2. Ethological performance of SCI rats confirmed improvement and protection of physiological function by Nec-1. Nec-1 as a potential treatment for SCI warrants further study. To our knowledge, this is the first study on the role of Nec-1 in the treatment of traumatic SCI. Our research also found inhibition effects of Nec-1 on apoptosis, not only necroptosis - as reported by most publications.Entities:
Keywords: apoptosis; cell protection; necroptosis; necrostatin-1; physiological function; spinal cord injury
Mesh：
Substances：
Year: 2014 PMID： 24561219 DOI： 10.1016/j.neuroscience.2014.02.007
Source DB: PubMed Journal: Neuroscience ISSN： 0306-4522 Impact factor: 3.590